Amanda J. Pierz,
PhD, MSc
As part of the Future Talent Program at Merck, Amanda was a doctoral intern at the HPV Vaccine Outcomes team in the Center for Observational and Real-World Evidence (CORE) for the summer of 2024.
Under the direction of Dr. Marcie Fisher-Borne, she supported the analysis and write up of a manuscript on implementation barriers and opportunities in pharmacy-based settings in the US and Canada. While the paper is under review with Vaccines, Dr. Fisher-Borne presented the preliminary findings at EUROGIN.
Amanda additionally supported the work of the Implementation Cross-Functional Team internally at Merck to launch of the SCALE framework and Merck-wide definition of implementation research to harmonize approaches to implementation science. This consisted of designing and drafting tools for markets to assess their current and upcoming evidence-based interventions to enhance HPV vaccination uptake.
After her internship ended, she stayed on with the HPV Vaccine Outcomes team at Merck as a consultant. She is currently supporting Dr. Xuedan You on a cross-sectional, mixed-methods study to assess the disease burden and unmet needs among patients living with anogenital warts in China. The project is currently wrapping up analysis and preparing for dissemination, while plans are underway to replicate this study in Japan.